Clinical Roundup In phase II study, Talzenna shrank tumors in breast cancer patients with PALB2 mutations October 28, 2022Vol.48 No.39
Clinical Roundup New analysis finds sequencing androgen-deprivation therapy with radiation therapy improves outcomes in localized prostate cancer October 28, 2022Vol.48 No.39
Clinical Roundup Metastasis-directed radiation therapy plus hormone therapy improves PFS for men with advanced prostate cancer October 28, 2022Vol.48 No.39
Clinical Roundup VCU Massey scientists pinpoint druggable target in TNBC October 28, 2022Vol.48 No.39
Clinical Roundup FLASH radiation therapy shows promise in first-in-human trial October 28, 2022Vol.48 No.39
Clinical Roundup Analysis of radiotherapy and locoregional recurrence in RxPONDER patients October 28, 2022Vol.48 No.39
Clinical Roundup Phase III pancreatic cancer study launched with OS primary endpoint for patients receiving MRI-guided ablative radiation therapy October 21, 2022Vol.48 No.38
Clinical Roundup Baylor study points to strategy to suppress prostate cancer growth October 21, 2022Vol.48 No.38
Clinical Roundup Researchers discover how bacteria make pancreatic cancer cells grow and move October 21, 2022Vol.48 No.38
Clinical Roundup Individuals with inflammatory breast cancer at higher risk of cancer spread to the brain October 14, 2022Vol.48 No.37
